Page last updated: 2024-10-24

candesartan and Aneurysm, Thoracic Aortic

candesartan has been researched along with Aneurysm, Thoracic Aortic in 1 studies

candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.

Research Excerpts

ExcerptRelevanceReference
"Acute-on-chronic type B aortic dissection, complicated by aneurysmal dilatation of the thoracic aorta and visceral malperfusion."1.33Staged endovascular treatment for complicated type B aortic dissection. ( Amukotuwa, SA; McLachlan, CS; Mossop, PJ; Nixon, IK, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mossop, PJ1
McLachlan, CS1
Amukotuwa, SA1
Nixon, IK1

Other Studies

1 other study available for candesartan and Aneurysm, Thoracic Aortic

ArticleYear
Staged endovascular treatment for complicated type B aortic dissection.
    Nature clinical practice. Cardiovascular medicine, 2005, Volume: 2, Issue:6

    Topics: Acute Disease; Adult; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Aortic Dissection; Atenolol; Back

2005